新生内膜
阿达姆斯
血管平滑肌
再狭窄
基质细胞蛋白
小干扰RNA
细胞生物学
内膜增生
细胞外基质
医学
化学
基质金属蛋白酶
血栓反应素
生物
内科学
金属蛋白酶
核糖核酸
支架
生物化学
基因
平滑肌
作者
Li Wang,Jingang Zheng,Xue Bai,Bo Liu,Liu C,Qingbo Xu,Yi Zhu,Nanping Wang,Wei Kong,Xian Wang
出处
期刊:Circulation Research
[Lippincott Williams & Wilkins]
日期:2009-01-23
卷期号:104 (5): 688-698
被引量:217
标识
DOI:10.1161/circresaha.108.188425
摘要
The migration of vascular smooth muscle cells (VSMCs) plays an essential role during the development of atherosclerosis and restenosis. Extensive studies have implicated the importance of extracellular matrix (ECM)-degrading proteinases in VSMC migration. A recently described family of proteinases, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTs), is capable of degrading vascular ECM proteins. Here, we sought to determine whether ADAMTS-7 is involved in VSMC migration and neointima formation in response to vascular injury. ADAMTS-7 protein accumulated preferentially in neointima of the carotid artery wall after balloon injury. In primary VSMCs, ADAMTS-7 level was enhanced by the proinflammatory cytokine tumor necrosis factor alpha and growth factor platelet-derived growth factor-BB. ADAMTS-7 overexpression greatly accelerated and small interfering RNA knockdown markedly retarded VSMC migration/invasion in vitro. In addition, luminal delivery of ADAMTS-7 adenovirus to carotid arteries exacerbated intimal thickening nearly sixfold 7 days after injury. Conversely, perivascular administration of ADAMTS-7 small interfering RNA but not scramble small interfering RNA to injured arteries attenuated intimal thickening by 50% at 14 days after injury. Furthermore, ADAMTS-7 mediated degradation of the vascular ECM cartilage oligomeric matrix protein (COMP) in injured vessels. Replenishing COMP circumvented the promigratory effect of ADAMTS-7 on VSMCs. Enforced expression of COMP significantly suppressed VSMC migration and neointima formation postinjury, which indicates that ADAMTS-7 facilitated intimal hyperplasia through degradation of inhibitory matrix protein COMP. ADAMTS-7 may therefore serve as a novel therapeutic target for atherosclerosis and postangioplasty restenosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI